Special Counsel Eric Berg was quoted in a Compliance Week article, “As SEC Targets EB-5 Fraud, the Visa Program Could Raise Money Laundering Risks,” on March 29, 2016. The article discussed the increasing use of the Employment-Based Fifth (EB-5) Preference program, which encourages capital investment in the United States by foreign investors in exchange for “green cards.” The program has come under scrutiny in regards to money laundering and the Securities and Exchange Commission (SEC) has started targeting the program.
Berg discussed how financial institutions have yet to be targeted, even after the SEC has begun working with the Financial Industry Regulatory Authority. He was quoted saying, “The government is paying more attention to the corrupt acquisition of wealth overseas. The risk to financial institutions is determining how the wealth was obtained and trying, to the best of their ability, not to deal with tainted funds. When foreign investors bring money into this country, it would probably behoove you to do more than the standard due diligence you would for opening a checking and savings account.”
Berg discussed how financial institutions have yet to be targeted, even after the SEC has begun working with the Financial Industry Regulatory Authority. He was quoted saying, “The government is paying more attention to the corrupt acquisition of wealth overseas. The risk to financial institutions is determining how the wealth was obtained and trying, to the best of their ability, not to deal with tainted funds. When foreign investors bring money into this country, it would probably behoove you to do more than the standard due diligence you would for opening a checking and savings account.”
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.